Physician profile
Joseph Abraham
NPI 1174152771
$1,966.38
in general payments reported to CMS, 2019-2025
6 companies · $750 in 2025
The $750 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.11 · 2022: $310 · 2023: $79.59 · 2024: $799 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,433 · Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,433.20 |
| Food and Beverage | $195.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $1,433.20 | 2024-2025 | |
| Alcon Vision LLC | $167.56 | 2021-2024 | Hydrus Microstent |
| Apellis Pharmaceuticals, INC. | $148.22 | 2022 | |
| Bausch & Lomb Americas INC. | $120.95 | 2022-2023 | Stellaris |
| Genentech USA, INC. | $83.19 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.